Literature DB >> 16601891

Atypical phenotype in a boy with a maple syrup urine disease.

T I Ben-Omran1, S Blaser, H Phillips, J Callahan, A Feigenbaum.   

Abstract

Maple syrup urine disease (MSUD) is a metabolic disorder due to a block in the decarboxylation step in the catabolic pathways of the branched-chain amino acids (BCAAs). We describe an atypical presentation in an infant male. The patient presented with psychomotor retardation, profound hypotonia and elevated plasma levels of BCAAs, but no elevation of alloisoleucine. Cranial magnetic resonance imaging showed prominent diffuse CSF spaces, delayed myelin maturation and symmetrical signal abnormality within the globi pallidi, midbrain, dorsal pons and medulla. The cerebellar white matter was specifically spared. A mitochondrial disorder was suggested. After correction of feeding problems with G-tube feeds, his high BCAAs persisted and, on fourth analysis, alloisoleucine was seen. Subsequent fibroblast enzyme and mutation analysis confirmed MSUD due to E(1)-alpha subunit deficiency. After starting dietary treatment, there was no significant improvement in his hypotonia or his psychomotor development. However, the high signal within the globi pallidi had resolved. MSUD may have diverse clinical presentations, and should be considered in children who present with chronic psychomotor delay but no acute encephalopathic episodes. BCAA levels may not be very high, alloisoleucine may not always be detected in MSUD even with severe enzyme deficiency, and imaging may be misleading if seen in the chronic phase only.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601891     DOI: 10.1007/s10545-006-0224-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.

Authors:  P Schadewaldt; A Bodner-Leidecker; H W Hammen; U Wendel
Journal:  Pediatr Res       Date:  2001-05       Impact factor: 3.756

2.  Maple syrup disease presenting as paroxysmal dystonia.

Authors:  Teresa Temudo; Esmeralda Martins; Fátima Poças; Romeu Cruz; Laura Vilarinho
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

3.  CT and MRI in maple syrup urine disease.

Authors:  G Uziel; M Savoiardo; N Nardocci
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

4.  Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.

Authors:  P Schadewaldt; A Bodner-Leidecker; H W Hammen; U Wendel
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

5.  Intermittent form of maple syrup urine disease: report of one case.

Authors:  P H Li; J S Ma; C S Chi; S C Mak
Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi       Date:  1997 Nov-Dec

Review 6.  Maple syrup urine disease: it has come a long way.

Authors:  D T Chuang
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

7.  Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.

Authors:  J Brismar; A Aqeel; G Brismar; R Coates; G Gascon; P Ozand
Journal:  AJNR Am J Neuroradiol       Date:  1990 Nov-Dec       Impact factor: 3.825

8.  Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.

Authors:  Marco Henneke; Nadine Flaschker; Christoph Helbling; Martina Müller; Peter Schadewaldt; Jutta Gärtner; Udo Wendel
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

9.  Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.

Authors:  S Schönberger; B Schweiger; B Schwahn; M Schwarz; U Wendel
Journal:  Mol Genet Metab       Date:  2004-05       Impact factor: 4.797

10.  Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease.

Authors:  W Heindel; H Kugel; U Wendel; B Roth; G Benz-Bohm
Journal:  Pediatr Radiol       Date:  1995
View more
  2 in total

1.  Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning.

Authors:  Mona Sajeev; Sharon Chin; Gladys Ho; Bruce Bennetts; Bindu Parayil Sankaran; Bea Gutierrez; Beena Devanapalli; Adviye Ayper Tolun; Veronica Wiley; Janice Fletcher; Maria Fuller; Shanti Balasubramaniam
Journal:  Int J Neonatal Screen       Date:  2021-05-14

Review 2.  Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.

Authors:  Jing Xu; Youseff Jakher; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.